Related Experiment Video
Updated: May 9, 2025

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Correlation of METTL4 genetic variants and severe pneumonia pediatric patients in Southern China
Liuheyi Ma1, Xiaoyu Zuo2, Bingtai Lu3,4
1School of Medicine, South China University of Technology, Guangzhou, 510006, China.
Insights
Genetic variations in the METTL4 gene are linked to increased severe pneumonia risk in children. This study identifies METTL4 as a potential predisposing gene for pediatric severe pneumonia.
Area of Science:
- Genetics
- Pediatrics
- Molecular Biology
Background:
- Pneumonia poses a significant global health burden in children under five.
- The genetic factors contributing to pneumonia susceptibility are not well understood.
- Methyltransferase 4, N6-adenosine (METTL4) is involved in RNA/DNA methylation and activated under hypoxia.
Purpose of the Study:
- To investigate the association between genetic variations in the METTL4 gene and severe pneumonia risk in children.
- To identify specific single nucleotide polymorphisms (SNPs) within METTL4 that may predispose individuals to severe pneumonia.
Main Methods:
- A cohort study involving 1034 children with severe pneumonia and 8426 healthy controls.
- Analysis of candidate regulatory single nucleotide polymorphisms (SNPs) within the METTL4 gene.
- Utilized expression quantitative trait loci (eQTLs), RegulomeDB, and FORGEdb to assess SNP regulatory potential in lung tissue.
Main Results:
- The C allele of rs9989554 was significantly associated with an increased risk of severe pneumonia (P=0.00023, OR=1.21).
- The G allele of rs16943442 also showed a significant association with increased severe pneumonia risk (P=0.0026, OR=1.22).
- Both identified SNPs demonstrated regulatory potential in lung tissue.
Conclusions:
- This study is the first to link genetic variations in METTL4 to severe pneumonia susceptibility in pediatric populations.
- METTL4 is identified as a novel predisposing gene for severe pneumonia.
- Further research is needed to validate these findings and explore the biological mechanisms of METTL4 in severe pneumonia.
Background:
Pneumonia is a major cause of mortality and health burden in children under five, yet its genetic etiology remains poorly understood. Methyltransferase 4, N6-adenosine (METTL4), is a methyltransferase enzyme responsible for RNA and DNA methylation and is known to be activated under hypoxic conditions. However, its potential link to susceptibility to pneumonia has not been evaluated. This study aimed to explore candidate regulatory single nucleotide polymorphisms (SNPs) within the METTL4 gene and their association with the development of severe pneumonia.
Results:
In this study, we recruited a cohort of 1034 children with severe pneumonia and 8426 healthy controls. We investigated the associations of candidate regulatory single nucleotide polymorphisms (SNPs) within METTL4 polymorphisms with severe pneumonia. Our results indicated that the C allele of rs9989554 (P = 0.00023, OR = 1.21, 95% CI: 1.09-1.34) and the G allele of rs16943442 (P = 0.0026, OR = 1.22, 95% CI: 1.07-1.38) were significantly associated with an increased risk of severe pneumonia. The regulatory potential of these two SNPs in the lung was investigated using tools such as expression quantitative trait loci (eQTLs), RegulomeDB, and FORGEdb.
Conclusions:
This study represents the first investigation elucidating the role of genetic variations in the METTL4 gene and their influence on susceptibility to severe pneumonia in pediatric populations. METTL4 is identified as a novel predisposing gene for severe pneumonia and a potential therapeutic target. Further research is warranted to validate this correlation and to comprehensively elucidate the biological role of the METTL4 gene in severe pneumonia.
More Related Videos
Related Concept Videos
Single Nucleotide Polymorphisms-SNPs
Pleiotropy
Lung Capacity
Pneumonia III: Complications and Assessment
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

